Evropská unie -
čeština -
EMA (European Medicines Agency)
beyfortus
astrazeneca ab - nirsevimab - imunitní séra a imunoglobuliny, - beyfortus is indicated for the prevention of respiratory syncytial virus (rsv) lower respiratory tract disease in neonates and infants during their first rsv season. beyfortus should be used in accordance with official recommendations.
Evropská unie -
čeština -
EMA (European Medicines Agency)
amvuttra
alnylam netherlands b.v. - vutrisiran sodium - amyloid neuropathies, familial - další léky na nervový systém - treatment of hereditary transthyretin-mediated amyloidosis (hattr amyloidosis) in adult patients with stage 1 or stage 2 polyneuropathy.
Evropská unie -
čeština -
EMA (European Medicines Agency)
hemgenix
csl behring gmbh - etranacogene dezaparvovec - hemofilie b - other hematological agents - treatment of severe and moderately severe haemophilia b (congenital factor ix deficiency) in adult patients without a history of factor ix inhibitors.
Česká republika -
čeština -
SUKL (Státní ústav pro kontrolu léčiv)
aprokam 50mg prášek pro injekční roztok
laboratoires thea, clermont-ferrand array - 4710 sodnÁ sŮl cefuroximu - prášek pro injekční roztok - 50mg - cefuroxim